FFTY vs. BOUT
Compare and contrast key facts about Innovator IBD 50 ETF (FFTY) and Innovator IBD Breakout Opportunities ETF (BOUT).
FFTY and BOUT are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FFTY is a passively managed fund by Innovator that tracks the performance of the IBD 50 Index. It was launched on Apr 9, 2015. BOUT is a passively managed fund by Innovator that tracks the performance of the IBD Breakout Stocks Index. It was launched on Sep 13, 2018. Both FFTY and BOUT are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FFTY or BOUT.
Correlation
The correlation between FFTY and BOUT is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FFTY vs. BOUT - Performance Comparison
Key characteristics
FFTY:
0.87
BOUT:
1.24
FFTY:
1.31
BOUT:
1.76
FFTY:
1.16
BOUT:
1.22
FFTY:
0.41
BOUT:
1.30
FFTY:
3.58
BOUT:
6.35
FFTY:
6.28%
BOUT:
3.43%
FFTY:
25.85%
BOUT:
17.52%
FFTY:
-59.46%
BOUT:
-36.76%
FFTY:
-42.57%
BOUT:
-7.12%
Returns By Period
In the year-to-date period, FFTY achieves a 1.43% return, which is significantly higher than BOUT's 0.82% return.
FFTY
1.43%
-7.67%
3.61%
26.09%
-3.04%
N/A
BOUT
0.82%
-5.29%
12.50%
24.77%
14.34%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FFTY vs. BOUT - Expense Ratio Comparison
FFTY has a 0.80% expense ratio, which is lower than BOUT's 0.84% expense ratio.
Risk-Adjusted Performance
FFTY vs. BOUT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator IBD 50 ETF (FFTY) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FFTY vs. BOUT - Dividend Comparison
FFTY has not paid dividends to shareholders, while BOUT's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
FFTY Innovator IBD 50 ETF | 0.00% | 0.00% | 0.64% | 2.75% | 0.22% | 0.00% | 0.00% | 0.00% | 0.17% |
BOUT Innovator IBD Breakout Opportunities ETF | 0.02% | 0.02% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% | 0.00% |
Drawdowns
FFTY vs. BOUT - Drawdown Comparison
The maximum FFTY drawdown since its inception was -59.46%, which is greater than BOUT's maximum drawdown of -36.76%. Use the drawdown chart below to compare losses from any high point for FFTY and BOUT. For additional features, visit the drawdowns tool.
Volatility
FFTY vs. BOUT - Volatility Comparison
Innovator IBD 50 ETF (FFTY) has a higher volatility of 10.52% compared to Innovator IBD Breakout Opportunities ETF (BOUT) at 6.42%. This indicates that FFTY's price experiences larger fluctuations and is considered to be riskier than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.